KRON4 News

Helius to Highlight Innovative PoNS Therapy™ at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS Day

NEWTOWN, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies (Nasdaq:HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for gait deficits, is ...
Everyday Health

How Does the PoNS Neurostimulation Device Help With Walking in MS?

For many people living with multiple sclerosis (MS), walking can become one of the most challenging daily tasks. As many as 3 in 4 people with MS have gait issues caused by factors like loss of muscle ...
Nasdaq

Helius Medical Technologies to Present PoNS® Device Study Results for Multiple Sclerosis at CMSC Annual Meeting 2025

Helius Medical Technologies, Inc. announced that it will present results from its new study on the Portable Neuromodulation Stimulator (PoNS®) at the upcoming Consortium of Multiple Sclerosis Centers ...
Nasdaq

Helius Medical Technologies Announces Positive Results from PoNS Stroke Registrational Program Supporting Planned FDA Submission for Gait and Balance Therapy

Helius Medical Technologies, Inc. announced positive outcomes from its Portable Neuromodulation Stimulator (PoNS) Stroke Registrational Program (SRP), which supports a planned FDA submission for ...
Seeking Alpha

Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System

NEWTOWN, Pa., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation ...